Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Trial to Use Stereotactic Body Radiotherapy for Head and Neck Tumors

NCT01344356 is registered in ClinicalTrials.gov with Mercy Research as lead sponsor.

NCT NCT01344356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01344356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Trial to Use Stereotactic Body Radiotherapy for Head and Neck Tumors
Lead sponsor
Mercy Research
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2008
Completion date
May 31, 2018
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angiofibroma of head and neck, chondrosarcoma of head and neck, chordoma of head and neck, head and neck sarcoma, nasopharyngeal carcinoma, paraganglioma of head and neck, salivary gland cancer, squamous cell carcinoma of the head and neck